CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-07 | Donovan Michael Patrick VP Operations | Sale | −36,310 | $8.81 | $320K | 35,708 |
| 2024-03-07 | Freitag Gregory Gene Director | Sale | −25,000 | $9.00 | $225K | 271,594 |
| 2024-03-01 | DeVinney Erick Wayne Chief Innovation Officer | Grant or award | +50,000 | 163,377 | ||
| 2024-02-22 | Kemp Jens Chief Marketing Officer | Grant or award · Performance Stock Units | +68,600 | 68,600 | ||
| 2024-02-22 | DeVinney Erick Wayne VP Peripheral Nerve Science | Grant or award · Performance Stock Units | +68,600 | 68,600 | ||
| 2024-02-22 | Began Marc A EVP and General Counsel | Grant or award · Performance Stock Units | +68,600 | 68,600 | ||
| 2024-01-01 | Naor Nir CFO | Grant or award | +300,000 | 300,000 | ||
| 2023-12-20 | Weiler Kathy Johnson Director | Grant or award · Stock Option (right to purchase) | +65,476 | $6.95 | $455K | 65,476 |
| 2023-12-11 | MARIANI PETER J EVP & Chief Financial Officer | Sale | −1,410 | $7.52 | $11K | 74,693 |
| 2023-12-11 | MARIANI PETER J EVP & Chief Financial Officer | Sale | −3,120 | $7.51 | $23K | 71,573 |
| 2023-12-11 | MARIANI PETER J EVP & Chief Financial Officer | Sale | −7,970 | $7.50 | $60K | 63,603 |
| 2023-10-13 | MARIANI PETER J EVP & Chief Financial Officer | Returned to the company | −3,263 | $4.04 | $13K | 76,103 |
| 2023-10-13 | DeVinney Erick Wayne VP Peripheral Nerve Science | Returned to the company | −864 | $4.04 | $3K | 113,377 |
| 2023-10-13 | Donovan Michael Patrick VP Operations | Returned to the company | −1,403 | $4.04 | $6K | 72,018 |
| 2023-10-13 | Scopelianos Angelo Chief R&D Officer | Returned to the company | −1,403 | $4.04 | $6K | 36,969 |
| 2023-10-13 | MARTINEZ MARIA D. Chief Human Resources Officer | Returned to the company | −1,403 | $4.04 | $6K | 30,476 |
| 2023-09-06 | Wendell Amy McBride Director | Purchase | +10,000 | $6.22 | $62K | 80,342 |
| 2023-09-01 | Wendell Amy McBride Director | Grant or award · Stock Option (right to purchase) | +20,436 | 20,436 | ||
| 2023-09-01 | Wendell Amy McBride Director | Grant or award · Restricted Stock Units | +11,904 | 11,904 | ||
| 2023-09-01 | Burke William P. Mr. Director | Grant or award · Employee Stock Option (right to purchase) | +20,436 | 20,436 |
Page 15 of 61 · 1,220 trades